High-risk neuroblastoma in Mexico: from multimodal treatment to immunotherapy. Regarding the first case treated with naxitamab
Front Oncol. 2025 Jun 18;15:1520171. doi: 10.3389/fonc.2025.1520171. eCollection 2025. ABSTRACT INTRODUCTION: We report herein the case of a patient diagnosed with high-risk neuroblastoma (HR-NB), treated …